{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:57:23Z","timestamp":1791341843722,"version":"4.3.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Washington State Department of Social and Health Services Research and Data Analysis division"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.drugalcdep.2019.107799","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T20:10:53Z","timestamp":1576008653000},"page":"107799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4084-6943","authenticated-orcid":false,"given":"C.J.","family":"Banta-Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Sears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.I.","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.J.","family":"Hoeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.107799_bib0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/SAR.S192045","article-title":"Opioid use disorder treatment decision making and care navigation upon release from prison: a feasibility study","volume":"10","author":"Banta-Green","year":"2019","journal-title":"Subst. Abuse Rehabil."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1360-0443.2009.02538.x","article-title":"Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users","volume":"104","author":"Banta-Green","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0015","series-title":"Washington State Syringe Exchange Health Survey: 2017 Results [WWW Document]","author":"Banta-Green","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0020","first-page":"7","article-title":"Prisoners\u2019 rights in the modern era individuals newly released from incarceration","author":"Beletsky","year":"2015","journal-title":"Northeast. Univ. Law J."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0025","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.drugalcdep.2017.11.023","article-title":"A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: findings at 12 months post-release","volume":"184","author":"Brinkley-Rubinstein","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0035","series-title":"Model Selection and Model Averaging","first-page":"70","article-title":"The Bayesian information criterion","author":"Claeskens","year":"2010"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0040","first-page":"1964","article-title":"The impact of prior authorization on buprenorphine dose, relapse rates, and cost for Massachusetts Medicaid beneficiaries with opioid dependence","volume":"49","author":"Clark","year":"2014","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0045","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1377\/hlthaff.2010.0532","article-title":"The evidence doesn\u2019t justify steps by state Medicaid programs to restrict opioid addiction treatment with buprenorphine","volume":"30","author":"Clark","year":"2011","journal-title":"Health Aff. (Millwood)"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0050","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1360-0443.2005.01050.x","article-title":"Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection","volume":"100","author":"Dolan","year":"2005","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.drugalcdep.2019.107799_bib0055","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1007\/s11606-012-2077-6","article-title":"Shared decision making: a model for clinical practice","volume":"27","author":"Elwyn","year":"2012","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1475-6773.2005.00466.x","article-title":"Benefit-cost in the California treatment outcome project: does substance abuse treatment \u201cpay for itself\u201d","volume":"41","author":"Ettner","year":"2006","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jsat.2014.07.015","article-title":"Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants","volume":"48","author":"Fox","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13722-014-0023-0","article-title":"Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder","volume":"10","author":"Fox","year":"2015","journal-title":"Addict. Sci. Clin. Pract."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0075","article-title":"Interest in getting help to reduce or stop substance use among syringe exchange clients who use opioids","volume":"1","author":"Frost","year":"2018","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0080","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/0017896914550321","article-title":"Development of an incarceration-specific overdose prevention video: staying alive on the outside","volume":"74","author":"Green","year":"2014","journal-title":"Health Educ. J."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0090","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/add.13238","article-title":"Long-term outcomes after randomization to buprenorphine\/naloxone versus methadone in a multi-site trial","volume":"111","author":"Hser","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11524-010-9525-6","article-title":"Risk factors for nonfatal overdose at seattle-area syringe exchanges","volume":"88","author":"Jenkins","year":"2011","journal-title":"J. Urban Health"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0100","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1056\/NEJM200011023431802","article-title":"A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence","volume":"343","author":"Johnson","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0105","series-title":"Post-Incarcerated Mothers\u2019 Perceptions of Their Relationships with Their Children and Patterns of Re-Offense. ProQuest Diss. Theses","author":"Johnson","year":"2007"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/00952990.2011.643983","article-title":"A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients","volume":"38","author":"Kelly","year":"2012","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jsat.2009.03.002","article-title":"A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease","volume":"37","author":"Kinlock","year":"2009","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.drugalcdep.2019.107799_bib0125","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/ajad.12533","article-title":"Hospitalized opioid-dependent patients: exploring predictors of buprenorphine treatment entry and retention after discharge","volume":"26","author":"Lee","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0135","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/add.12894","article-title":"Opioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trial","volume":"110","author":"Lee","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0150","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jsat.2017.07.001","article-title":"Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population","volume":"85","author":"Morgan","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0160","article-title":"Drug use and dependence, state and federal prisoners, 2004","author":"Mumola","year":"2006","journal-title":"Bur. Justice Stat. Spec. Rep."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0165","series-title":"Office-based Buprenorphine Treatment: Identifying Factors That Promote Retention in Opioid Dependent Patients","first-page":"41","author":"Noe","year":"2012"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0170","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/08897077.2017.1393034","article-title":"Being able to speak: what individuals in jail perceived as helpful about participating in alcohol-related brief interventions","volume":"39","author":"Owens","year":"2018","journal-title":"Subst. Abus."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsat.2016.12.011","article-title":"A randomized study of the use of screening, brief intervention, and referral to treatment (SBIRT) for drug and alcohol use with jail inmates","volume":"74","author":"Prendergast","year":"2017","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0180","series-title":"Women, Re-Entry and Everyday Life: Time to Work?","author":"Rose","year":"2008"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0185","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ADM.0b013e3181db6b67","article-title":"Screening and brief intervention for unhealthy drug use in primary care settings: randomized clinical trials are needed","volume":"4","author":"Saitz","year":"2010","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0190","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","article-title":"Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees","volume":"95","author":"Samples","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"issue":"4","key":"10.1016\/j.drugalcdep.2019.107799_bib0195","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jfda.2013.09.037","article-title":"Medication-assisted treatment for opioid addiction: methadone and buprenorphine","volume":"21","author":"Saxon","year":"2013","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0200","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10550490802268835","article-title":"Attitudes toward buprenorphine and methadone among opioid-dependent individuals","volume":"17","author":"Schwartz","year":"2008","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0205","article-title":"Families left behind: the hidden costs of incarceration and reentry","author":"Travis","year":"2005","journal-title":"Children"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0210","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0215","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/journalofethics.2017.19.9.stas1-1709","article-title":"Why it\u2019s inappropriate not to treat incarcerated patients with opioid agonist therapy","volume":"19","author":"Wakeman","year":"2017","journal-title":"AMA J. Ethics"},{"key":"10.1016\/j.drugalcdep.2019.107799_bib0220","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s11606-008-0686-x","article-title":"Office-based management of opioid dependence with buprenorphine: clinical practices and barriers","volume":"23","author":"Walley","year":"2008","journal-title":"J. Gen. Intern. Med."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619305769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619305769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:01:40Z","timestamp":1759827700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619305769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":44,"alternative-id":["S0376871619305769"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107799","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of a jail-based treatment decision-making intervention on post-release initiation of medications for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.107799","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107799"}}